BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 8163516)

  • 21. Defective binding of 3-methylcholanthrene to the Ah receptor within C3H/1OT1/2 clone 8 mouse fibroblasts in culture.
    Okey AB; Mason ME; Gehly EB; Heidelberger C; Muncan J; Dufresne MJ
    Eur J Biochem; 1983 May; 132(2):219-27. PubMed ID: 6301823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of aryl hydrocarbon hydroxylase and demonstration of a specific nuclear receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in two human hepatoma cell lines.
    Labruzzo P; Yu XF; Dufresne MJ
    Biochem Pharmacol; 1989 Jul; 38(14):2339-48. PubMed ID: 2546564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the 4-5S binding protein in the induction of aryl hydrocarbon hydroxylase in the rat.
    Harris M; Kamps C; Safe S
    Carcinogenesis; 1988 Aug; 9(8):1475-9. PubMed ID: 3402044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation.
    Carrier F; Owens RA; Nebert DW; Puga A
    Mol Cell Biol; 1992 Apr; 12(4):1856-63. PubMed ID: 1312672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicochemical characterization of the nuclear form of Ah receptor from mouse hepatoma cells exposed in culture to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Prokipcak RD; Okey AB
    Arch Biochem Biophys; 1988 Dec; 267(2):811-28. PubMed ID: 2850772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of action of alpha-naphthoflavone as an inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
    Merchant M; Arellano L; Safe S
    Arch Biochem Biophys; 1990 Aug; 281(1):84-9. PubMed ID: 2166479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.
    Harris M; Zacharewski T; Astroff B; Safe S
    Mol Pharmacol; 1989 May; 35(5):729-35. PubMed ID: 2542761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces the nuclear translocation of two XRE binding proteins in mice.
    Okino ST; Pendurthi UR; Tukey RH
    Pharmacogenetics; 1993 Apr; 3(2):101-9. PubMed ID: 8390902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of o,p'-DDT on the 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible CYP1A1 expression in murine Hepa-1c1c7 cells.
    Jeong HG; Kim JY
    Food Chem Toxicol; 2002 Nov; 40(11):1685-92. PubMed ID: 12176094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of cytochrome P450IA1 in mouse hepatoma cells by several chemicals. Phenobarbital and TCDD induce the same form of cytochrome P450.
    Kärenlampi SO; Tuomi K; Korkalainen M; Raunio H
    Biochem Pharmacol; 1989 May; 38(9):1517-25. PubMed ID: 2541728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene.
    Li W; Harper PA; Tang BK; Okey AB
    Biochem Pharmacol; 1998 Sep; 56(5):599-612. PubMed ID: 9783729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
    Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S
    Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-substituted 3,4-benzocoumarins: a new structural class of inducers and inhibitors of CYP1A1-dependent activity.
    Liu H; Santostefano M; Lu Y; Safe S
    Arch Biochem Biophys; 1993 Oct; 306(1):223-31. PubMed ID: 8215408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of the regulatory domains of the murine Cyp1a1 gene with two DNA-binding proteins in addition to the Ah receptor and the Ah receptor nuclear translocator (ARNT).
    Carrier F; Chang CY; Duh JL; Nebert DW; Puga A
    Biochem Pharmacol; 1994 Nov; 48(9):1767-78. PubMed ID: 7980646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of [Ah] gene battery enzymes and glutathione levels by 5,10-dihydroindeno[1,2-b]indole in mouse hepatoma cell lines.
    Liu RM; Vasiliou V; Zhu H; Duh JL; Tabor MW; Puga A; Nebert DW; Sainsbury M; Shertzer HG
    Carcinogenesis; 1994 Oct; 15(10):2347-52. PubMed ID: 7955076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells.
    Lu YF; Santostefano M; Cunningham BD; Threadgill MD; Safe S
    Arch Biochem Biophys; 1995 Jan; 316(1):470-7. PubMed ID: 7840652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase.
    Poland A; Glover E; Kende AS
    J Biol Chem; 1976 Aug; 251(16):4936-46. PubMed ID: 956169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative studies of aryl hydrocarbon hydroxylase and the Ah receptor in nonmammalian species.
    Denison MS; Hamilton JW; Wilkinson CF
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 80(2):319-24. PubMed ID: 2861016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ligand structure on the in vitro transformation of the rat cytosolic aryl hydrocarbon receptor.
    Santostefano M; Piskorska-Pliszczynska J; Morrison V; Safe S
    Arch Biochem Biophys; 1992 Aug; 297(1):73-9. PubMed ID: 1322114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diflubenzuron, a benzoyl-urea insecticide, is a potent inhibitor of TCDD-induced CYP1A1 expression in HepG2 cells.
    Ledirac N; Delescluse C; Lesca P; Piechocki MP; Hines RN; de Sousa G; Pralavorio M; Rahmani R
    Toxicol Appl Pharmacol; 2000 May; 164(3):273-9. PubMed ID: 10799337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.